Open AccessSelf-monitoring of blood glucose in patients with type 2 diabetes mellitus from the standpoint of evidence-based medicine
Author(s) -
Vadim Zakiev,
Violetta R. Mustafina
Publication year - 2022
Publication title -
medicinskij vestnik ûga rossii
Language(s) - English
Resource type - Journals
eISSN - 2618-7876
pISSN - 2219-8075
DOI - 10.21886/2219-8075-2022-13-1-43-51
Subject(s) - glycated hemoglobin , medicine , united kingdom prospective diabetes study , diabetes mellitus , type 2 diabetes mellitus , continuous glucose monitoring , hemoglobin , intensive care medicine , type 2 diabetes , type 1 diabetes , endocrinology
According to clinical guidelines self-monitoring of blood glucose is a part of the treatment of type 2 diabetes mellitus. However, self-monitoring of glycemia is associated with signifi cant costs. Th at’s why the issue if there is a possibility to decrease the use of self-monitoring of blood glucose is actual. Since the United Kingdom Prospective Study (UKPDS) showed that every 1% decrease in glycated hemoglobin leads to a 37% decrease in the risk of microvascular complications and 14% decrease in the risk of macrovascular complications as well as it leads to a decrease in mortality, the article mainly examined the eff ect of selfmonitoring on the level of glycated hemoglobin in various clinical situations.